Cargando…

PM382. Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study.

Detalles Bibliográficos
Autores principales:	Chou, Po-Han, Chu, Che-Sheng, Lin, Ching-Heng, Huang, Min-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616318/ http://dx.doi.org/10.1093/ijnp/pyw041.382

Ejemplares similares

PM441. Long term atypical antipsychotic treatment improves cognitive performance in schizophrenia but not surpassing conventional antipsychotic drugs effects.
por: Vera, Gabriel Selva, et al.
Publicado: (2016)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

PM390. Comparison of Fast Versus Slow Strategy in Switching Schizophrenia Patients to Aripiprazole from Other Antipsychotics
por: Hwang, Tzung-Jeng, et al.
Publicado: (2016)

PM440. The Effects of An Atypical Antipsychotic on the Mr 32 kDa Related Signaling Pathways
por: Park, Hanson
Publicado: (2016)

PM379. Quality of Life in patients with schizophrenia or bipolar disorder receiving long-acting antipsychotics
por: Lin, Shih-Ku
Publicado: (2016)

PM399. Attitudes toward antipsychotic long-acting injections among patients with Schizophrenia in Japan.
por: Kudo, Shuhei, et al.
Publicado: (2016)

PM524. VEGF may have a neuroprotective role in the improvement of schizophrenia or in the treatment effects of antipsychotics
por: Kim, Yongku, et al.
Publicado: (2016)

PM394. The outcome of paliperidone palmitate in schizophrenia
por: Ju, Po-Chung
Publicado: (2016)

New atypical antipsychotics for schizophrenia: iloperidone
por: Caccia, Silvio, et al.
Publicado: (2010)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

PM387. A preliminary study of antipsychotics polypharmacy among schizophrenia patients who admitted to national mental hospital
por: Han, Jaewook
Publicado: (2016)

PM527. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics
por: Melkersson, Kristina, et al.
Publicado: (2016)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Can atypical antipsychotic drugs cause hepatotoxicity?
por: André, R., et al.
Publicado: (2021)

PM397. Effectiveness of blonanserin in patients with schizophrenia: A systematic review and meta-analysis of direct head-to-head comparisons with other antipsychotics
por: Kishi, T., et al.
Publicado: (2016)

PM398. Fluctuations in hallucinatory experiences within a day in relation to dopamine D2 receptor blockade with antipsychotics in patients with schizophrenia
por: Koizumi, Teruki, et al.
Publicado: (2016)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
por: Jorge, B., et al.
Publicado: (2021)

Off-label use of atypical antipsychotics- Where are we?
por: Vaz, R. P., et al.
Publicado: (2023)

PM428. Combination of Clozapine with Long Acting Injectable Antipsychotics in Treatment Resistant Schizophrenia: Preliminary Evidence from Health Care Utilization Indices
por: Grimminck, Rachel, et al.
Publicado: (2016)

Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
por: Chen, Yi-Lung, et al.
Publicado: (2018)

Severity in schizophrenia patients receiving atypical antipsychotic medications
por: Alam Fatmi1j, Syed Meraj, et al.
Publicado: (2022)

Antipsychotic treatment and cognitive function in patients with schizophrenia
por: Tumova, M. A., et al.
Publicado: (2023)

PM464. Effect of Anhedonia on Shopping Behavior in Schizophrenia
por: Kim, Min-Kyeong, et al.
Publicado: (2016)

PM408. LONG-TERM ANTIPSYCHOTICS IN “HYSTERICAL PSYCHOSIS”: A CASE REPORT
por: Martinez Luna, F. Ramon, et al.
Publicado: (2016)

PM455. Genetic variants in Chromogranin B is associated with the Risk of Schizophrenia in Korean male population
por: Kim, Jiwon, et al.
Publicado: (2016)

T232. EFFICACY AND SAFETY OF ANTIDEPRESSANT AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA
por: Galling, Britta, et al.
Publicado: (2018)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
por: Lähteenvuo, M., et al.
Publicado: (2021)

Schizophrenia long-acting antipsychotics initiation index (SLAAII)
por: Ifteni, P., et al.
Publicado: (2021)

PM461. Inflammation in schizophrenia: Imaging genetics
por: Hwang, Wu Jeong, et al.
Publicado: (2016)

MED15/382: Co-operative Interface in Medical Education on the WWW
por: Courtin, C, et al.
Publicado: (1999)

382. Difference in Pathogens Between Hip and Knee Prosthetic Joint Infection
por: Henry, Michael, et al.
Publicado: (2019)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

PM520. Association between Schizophrenia and Urinary Incontinence: A Population-Based Study
por: Hsu, Wen Yu, et al.
Publicado: (2016)

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
por: Torrent, Carla, et al.
Publicado: (2010)

PM359. A prospective cohort study for metabolic measures during antipsychotic treatments in patients with schizophrenia and schizoaffective disorder: A cross-sectional analysis of baseline data
por: Kusumi, Ichiro, et al.
Publicado: (2016)

PM438. Functional connectivity and striatal dopamine synthesis in schizophrenia treated with antipsychotic drugs: multimodal imaging study using [18F]DOPA PET and resting MRI
por: Kim, Euitae, et al.
Publicado: (2016)

T192. THE GUT MICROBIOME IN SCHIZOPHRENIA AND ANTIPSYCHOTIC INDUCED METABOLIC DYSFUNCTION
por: Kanji, Sarah, et al.
Publicado: (2018)

38.2 NEURONAL AUTOANTIBODIES IN PSYCHOSIS: ENOUGH ABOUT PREVALENCE, WHAT’S THE RELEVANCE?
por: Pollak, Thomas
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5rdujba14r2p7i1dlcbgnhm3mn